Research Article

Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia

Volume: 2 Number: 3 July 29, 2020
EN

Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia

Abstract

Although splenectomy is markedly effective treatment modality at early period in adult chronic immune thrombocytopenia (ITP), long-term outcomes are still controversial. The aim of this study was to determine long-term effectiveness and reliability of splenectomy in ITP and to identify factors influencing on long-term response. The study included 100 ITP patients who underwent splenectomy in our General Surgery Department between 1980 and 2004. Parameters including gender, age, platelet count, comorbid diseases, antiplatelet antibody positivity and long-term effect of medical treatment on response to splenectomy were considered. Owing to advances in treatment protocols, ITP has become a more benign disease and need for splenectomy has been decreased. However, splenectomy is a highly effective in second-line treatment. Based on our results, it was seen that open or laparoscopic splenectomy with low morbidity and mortality rates is an appropriate treatment modality for long-term control of chronic ITP in cases requiring splenectomy. Age and postoperative platelet count were identified as significant prognostic and predictive factors for long-term response to splenectomy.

Keywords

Supporting Institution

yok

Project Number

yok

Thanks

prof. dr rıdvan ali ve prof. dr yılmaz özen e teşekkürlerimi sunarım

References

  1. 1- Provan D, Newland A, Norfolk D, et al. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and İn pregnancy. British Journal of Haematology 2003;20:574-596.
  2. 2- Stasi R, Provan D. Management of Immune Thrombocytopenic Purpura İn Adults. Mayo Clin Proc 2004:79:504-522.
  3. 3- Fogarty PF. Chronic immune thrombocytopenia in adults: epidemiology and clinical presentation. Hematol Oncol Clin North Am. 2009;23(6):1213-1221.
  4. 4- Schoonen WM, Kucera G, Coalson J, et al. . Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145(2):235-244.
  5. 5- Moulis G, Palmaro A, Montastruc JL, et al. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124(22):3308-3315.
  6. 6- George JN, Raskolo GE. İdiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematology 1998; 35:5-8.
  7. 7- Shulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci. 1965;124(2):499-542.
  8. 8- Khodadi E, Asnafi AA, Shahrabi S, et al. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis. Ann Hematol. 2016;95(11):1765-1776.

Details

Primary Language

English

Subjects

​Internal Diseases

Journal Section

Research Article

Publication Date

July 29, 2020

Submission Date

July 10, 2020

Acceptance Date

July 18, 2020

Published in Issue

Year 2020 Volume: 2 Number: 3

APA
Narmanlı, M., Gürsoy, V., Ali, R., & Özen, Y. (2020). Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia. Turkish Journal of Internal Medicine, 2(3), 73-77. https://doi.org/10.46310/tjim.767946
AMA
1.Narmanlı M, Gürsoy V, Ali R, Özen Y. Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia. Turk J Int Med. 2020;2(3):73-77. doi:10.46310/tjim.767946
Chicago
Narmanlı, Mustafa, Vildan Gürsoy, Rıdvan Ali, and Yılmaz Özen. 2020. “Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia”. Turkish Journal of Internal Medicine 2 (3): 73-77. https://doi.org/10.46310/tjim.767946.
EndNote
Narmanlı M, Gürsoy V, Ali R, Özen Y (July 1, 2020) Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia. Turkish Journal of Internal Medicine 2 3 73–77.
IEEE
[1]M. Narmanlı, V. Gürsoy, R. Ali, and Y. Özen, “Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia”, Turk J Int Med, vol. 2, no. 3, pp. 73–77, July 2020, doi: 10.46310/tjim.767946.
ISNAD
Narmanlı, Mustafa - Gürsoy, Vildan - Ali, Rıdvan - Özen, Yılmaz. “Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia”. Turkish Journal of Internal Medicine 2/3 (July 1, 2020): 73-77. https://doi.org/10.46310/tjim.767946.
JAMA
1.Narmanlı M, Gürsoy V, Ali R, Özen Y. Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia. Turk J Int Med. 2020;2:73–77.
MLA
Narmanlı, Mustafa, et al. “Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia”. Turkish Journal of Internal Medicine, vol. 2, no. 3, July 2020, pp. 73-77, doi:10.46310/tjim.767946.
Vancouver
1.Mustafa Narmanlı, Vildan Gürsoy, Rıdvan Ali, Yılmaz Özen. Effectiveness and Reliability of Splenectomy in Chronic Immune Thrombocytopenia. Turk J Int Med. 2020 Jul. 1;2(3):73-7. doi:10.46310/tjim.767946

Cited By

30994   34277 29166

 

Turkish Journal of Internal Medicine, hosted by DERGİPARK, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png